MedPath

TEVA-DAPAGLIFLOZIN

TEVA-DAPAGLIFLOZIN

Approved
DIN Number

02523590

Drug Class

Human

Market Date

N/A

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02523590
AIG Number0156370001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BK01 DAPAGLIFLOZIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

DAPAGLIFLOZINActive
Strength: 5 MG
Monograph: DAPAGLIFLOZIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.